Dr. Kimberly Smith, a renowned US infectious disease specialist and Head of Research & Development for ViiV Healthcare, joins Ben on the podcast to talk about new data on cabotegravir as potential long-acting injectable HIV prevention technology, as well as new approaches to treat HIV with next generation medicines. She shares how she has led a global R&D operation in the era COVID-19 and what Black Lives Matters means to her as a leading African American clinician and pharmaceutical leader.

For more information:
https://viivhealthcare.com
https://bayareaglobalhealth.org
https://www.aids2020.org
https://coronavirus.ucsf.edu
https://www.who.int
https://www.cdc.gov
https://www.nih.gov

This episode was made in partnership with the Bay Area Global Health Alliance. You can find this episode and past episodes of A Shot in the Arm Podcast with Ben Plumley on all the major podcast platforms. Please subscribe and give us 5 stars!

--
www.ashotinthearmpodcast.com